The Little Company That Can

The Little Company That Can By Bob Grant Photo by Catherine Ledner ARTICLE EXTRAS Best Places to Work 2007 Sandoz stands out Top 30 Companies Top Large Companies Top Small Companies Most Important Factors Top Companies on the Most Important Factors Categories Best Places to Work: Survey Findings PDF Amylin Pharmaceuticals, a 20-year-old biopharmaceutical company based in San Diego, broke into ou

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


ARTICLE EXTRAS

Amylin Pharmaceuticals, a 20-year-old biopharmaceutical company based in San Diego, broke into our top ten last year and is the only small company to retain its Top Small Company ranking (seventh place) while growing significantly over the last two years. In 2005, Amylin netted $206 million, brought two first-in-class diabetes drugs to market, and has added 721 new employees over the last two years.

So how does this little company grow so much while remaining a great place to work?


The answer is simple: Amylin employees, no matter how large their company gets, take great pride in their work. Christian Weyer, executive director of the clinical research department at Amylin, says this sense of pride permeates the entire organization, from laboratory technicians to executive officers. "There is a lot of passion among people here for what they do," he says. Weyer adds that this shared sense of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies